- Home
- TPB vs ORIC Comparison
TPB vs ORIC Comparison
Compare TPB & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TPB | ORIC |
|---|---|---|
| Founded | 1988 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Tobacco | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TPB | ORIC |
|---|---|---|
| Price | $60.48 | $13.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | ★ $115.00 | $19.73 |
| AVG Volume (30 Days) | 318.6K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | ★ 45.33 | 19.67 |
| EPS | ★ 3.11 | N/A |
| Revenue | ★ $463,062,000.00 | N/A |
| Revenue This Year | $13.68 | N/A |
| Revenue Next Year | $11.32 | N/A |
| P/E Ratio | $19.51 | ★ N/A |
| Revenue Growth | ★ 28.39 | N/A |
| 52 Week Low | $58.57 | $7.23 |
| 52 Week High | $146.90 | $14.93 |
Technical Indicators
Market Signals| Indicator | TPB | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 25.58 | 52.88 |
| Support Level | N/A | $10.17 |
| Resistance Level | $91.03 | $14.27 |
| Average True Range (ATR) | 2.69 | 0.70 |
| MACD | -0.62 | 0.04 |
| Stochastic Oscillator | 13.19 | 58.41 |
Price Performance
Historical ComparisonAbout TPB Turning Point Brands Inc.
Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.